US Patent 10919915 Compounds as GPR119 agonists
Patent 10919915 was granted and assigned to Mankind Pharma Ltd on February, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+183 characters)
Article
Patent abstract
The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Anil Kumar0
Dharmesh Shah0
Jeevan Verma0
Rakesh Ishwar Patil0
Santosh Kumar Rai0
Sazid Ali0
Srinivasa Reddy Bapuram0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109199150
Date of Patent
February 16, 2021
0Patent Application Number
166011090
Date Filed
October 14, 2019
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10919915 Compounds as GPR119 agonists
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10919915
Date of patent
February 16, 2021
Patent application number
16601109
Date Filed
October 14, 2019
Patent primary examiner
Find more entities like US Patent 10919915 Compounds as GPR119 agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.